# Paliurus ramosissimus Leaf Extract Inhibits Adipocyte Differentiation In Vitro and In Vivo High-Fat Diet-Induced Obesity Through PPARγ Suppression

**Authors:** Shin-Hye Kim, Tae Hyun Son, Hye-Lim Shin, Dongsoo Kim, Gwang Hun Park, Jeong Won Seo, Hwan-Gyu Kim, Sik-Won Choi

PMC · DOI: 10.3390/ph18101515 · Pharmaceuticals · 2025-10-10

## TL;DR

Paliurus ramosissimus leaf extract reduces fat cell growth and obesity in mice by suppressing a key fat-regulating protein.

## Contribution

The study demonstrates PRLE's novel anti-obesity effects through PPARγ suppression in both cell and animal models.

## Key findings

- PRLE reduced lipid accumulation in 3T3-L1 cells without causing cell death.
- PRLE decreased the expression of key adipogenic genes like PPARγ and C/EBPα.
- In mice, PRLE reduced body weight gain and white adipose tissue mass on a high-fat diet.

## Abstract

Background/Objectives: Obesity, defined by the excessive accumulation of adipose tissue, is associated with an increased risk of type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD). Obesity treatments based on natural products are receiving increasing attention as viable alternatives to conventional treatments. Methods: To investigate the anti-obesity effects of Paliurus ramosissimus leaf extract (PRLE) in vitro and in vivo, we conducted studies using 3T3-L1 pre-adipocytes. The in vivo studies used high-fat diet (HFD)-fed C57BL/6 mice. PRLE effects were assessed through Oil Red O staining, RT-qPCR, Western blot, and morphological analysis of adipose tissue. Results: PRLE significantly reduced lipid accumulation in 3T3-L1 cells without cytotoxicity. PRLE treatment decreased mRNA expression of adipogenic genes (PPARγ, C/EBPα, FABP4, and leptin) and protein levels of adipogenesis-related markers. In HFD-fed mice, PRLE administration significantly reduced body weight gain (p < 0.001), decreased adipose tissue mass, and diminished the weight and size of white adipose tissue. Conclusions: PRLE exhibits anti-obesity effects both in vitro and in vivo, suggesting its potential as a therapeutic agent for obesity prevention.

## Linked entities

- **Genes:** PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050], FABP4 (fatty acid binding protein 4) [NCBI Gene 2167], lepa (leptin a) [NCBI Gene 106561227]
- **Diseases:** type 2 diabetes (MONDO:0005148), metabolic dysfunction-associated steatotic liver disease (MONDO:0013209), obesity (MONDO:0011122)

## Full-text entities

- **Genes:** Cebpa (CCAAT/enhancer binding protein alpha) [NCBI Gene 12606] {aka C/ebpalpha, CBF-A, Cebp}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, Fabp4 (fatty acid binding protein 4, adipocyte) [NCBI Gene 11770] {aka 422/aP2, AFABP, ALBP, ALBP/Ap2, Ap2, Lbpl}
- **Diseases:** type 2 diabetes (MESH:D003924), metabolic dysfunction (MESH:D008659), MASLD (MESH:D008107), weight gain (MESH:D015430), Obesity (MESH:D009765), cytotoxicity (MESH:D064420)
- **Chemicals:** PRLE (-), Oil Red O (MESH:C011049), lipid (MESH:D008055)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12566692/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12566692/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12566692/full.md

---
Source: https://tomesphere.com/paper/PMC12566692